Position in AMGN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$112,564,907
+$2,128,222 QoQ
Shares Held
319,923
-5.2% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $1,341,272,655 across 18 Drug Manufacturers - General names. AMGN ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,276,418 | $312,007,615 | |
| 2 | LLY |
ELI LILLY & Co
|
303,295 | $278,961,642 | |
| 3 | ABBV |
AbbVie Inc.
|
1,000,714 | $217,645,287 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,222,577 | $147,063,787 | |
| 5 | AMGN |
Amgen Inc
This page
|
319,923 | $112,564,907 | |
| 6 | PFE |
Pfizer Inc
|
3,488,515 | $97,957,501 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
992,662 | $60,204,950 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
258,398 | $36,012,929 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $112,564,907 | 319,923 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $110,436,685 | 337,407 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $105,578,921 | 374,128 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $114,977,281 | 411,795 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $129,734,716 | 416,417 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $104,056,349 | 399,234 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $124,809,976 | 387,356 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $120,877,531 | 386,870 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $112,027,766 | 394,020 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $110,334,125 | 383,078 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $100,995,170 | 375,782 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $80,920,295 | 364,473 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $91,753,795 | 379,540 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $89,914,541 | 342,349 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $76,063,709 | 337,461 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $81,855,122 | 336,437 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $81,594,178 | 337,417 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $74,085,545 | 329,313 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $67,630,568 | 318,037 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $76,263,037 | 312,874 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $74,942,069 | 301,202 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $69,325,708 | 301,521 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $78,925,067 | 310,533 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $74,467,606 | 315,728 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $60,741,557 | 299,618 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||